Article 1 to 1 out of 1 concerning UMN Pharma Inc.
Crucell and DSM Biologics Announce PER.C6 Licensing Agreement with UMN Pharma(03/10/2006) Crucell N.V. and allied contract manufacturer DSM Biologics announced that they have signed a PER.C6® research license agreement with Japanese pharmaceutical company UMN Pharma. This license agreement allows UMN Pharma to use the PER.C6® cell line ...
Top
